Polar Securities »

Nurix Therapeutics shares owned by Polar Securities

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Polar Securities from 13F filings

Historical chart of Polar Securities investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Polar Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Polar Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $607k 27k 22.47

More positions owned by Polar Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Sprott Physical Gold Tr Unit (PHYS)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Axon Enterprise Note 0.500%12/1 (Principal)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ppl Cap Fdg Note 2.875% 3/1 (Principal)
Interdigital Note 3.500% 6/0 (Principal)
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Cms Energy Corp Note 3.375% 5/0 (Principal)
Granite Constr Note 3.750% 5/1 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Sprott Physical Silver Tr Tr Unit (PSLV)
Fluor Corp Note 1.125% 8/1 (Principal)
Tetra Tech DBCV 2.250% 8/1 (Principal)
Post Hldgs Note 2.500% 8/1 (Principal)

View all positions for Polar Securities

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Baker Bros. Advisors
T. Rowe Price Associates
T. Rowe Price Investment Management
ARK Investment Management
Pictet Asset Management Holding SA
Commodore Capital
Citadel Advisors
Geode Capital Management
Driehaus Capital Management
Affinity Asset Advisors
Deutsche Bank Aktiengesellschaft
Daniel D. Thurber
Samlyn Capital

View all funds holding Nurix Therapeutics